The rising burden of cancer in the developing world

Annals of Oncology

Volumn 17, Issue SUPPL. 8, 2006, Pages

  Kanavos, P ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Burden of disease; Cancer epidemiology; Developing countries; Health services; Healthcare policy

Indexed keywords

HEPATITIS B VACCINE; WART VIRUS VACCINE;

ACCESS TO INFORMATION; ALCOHOL CONSUMPTION; ARTICLE; AWARENESS; CANCER; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RESEARCH; CANCER RISK; CANCER SURVIVAL; CANCER THERAPY; CHRONIC DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COLORECTAL CANCER; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIETARY INTAKE; EARLY DIAGNOSIS; EXERCISE; HEALTH CARE FINANCING; HEALTH CARE POLICY; HEPATITIS B; HUMAN; INDUSTRIALIZATION; INFECTION; INFORMED CONSENT; INTERNATIONAL COOPERATION; LIVER CELL CARCINOMA; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MORBIDITY; PRIORITY JOURNAL; RESOURCE MANAGEMENT; RISK ASSESSMENT; SURVIVAL RATE; UTERINE CERVIX CANCER; VERRUCA VULGARIS;

EID: 33745594629     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl983     Document Type: Article

References (56)

1. Sener SF, Grey N. The global burden of cancer. J Surg Oncol 2005; 92: 1-3.
2. Salminen E, Izewska J, Andreo P. IAEA's role in the global management of cancer-focus on upgrading radiotherapy services. Acta Oncol 2005; 44: 816-824.
3. World Health Organization. Global cancer rates could increase by 50% to 15 million by 2020 (April 3, 2003). [On-line], http:/www.who.int/ mediacentre/news/releases/2003/pr27/en/ (January 10, 2006, date last accessed).
4. Beaglehole R, Yach D. Globalisation and the prevention and control of noncommunicable disease: The neglected chronic diseases of adults. Lancet 2003; 362: 903-908.
5. Stewart BW, Kleihues P, International Agency for Research on Cancer. World cancer report. Lyon, France: IARC Press 2003.
6. Plesnicar S, Plesnicar A. Cancer: A reality in the emerging world. Semin Oncol 2001; 28: 210-216.
7. Denny L. The prevention of cervical cancer in developing countries. BJOG 2005; 112: 1204-1212.
8. Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0 2004.
9. Jones SB. Cancer in the developing world: A call to action. BMJ 1999; 319: 505-508.
10. Shibuya K, Mathers CD, Boschi-Pinto C et al. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2002; 2: 37.
11. Mathers C, Bernard C, Iburg K et al. Global Cancer Statistics. CA Cancer J Clin 1999; 49: 33-64.
12. Rastogi T, Hildesheim A, Sinha R. Opportunities for cancer epidemiology in developing countries. Nat Rev Cancer 2004; 4: 909-917.
13. Munoz N. Human papillomavirus and cancer: The epidemiological evidence. J Clin Virol 2000; 19: 1-5.
14. Parkin D. The global health burden of Infection-associated cancers in the year 2002. Int J Cancer 2006; 118; 3030-3044.
15. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 2003; 89: 101-105.
16. Koutsky LA, Ault KA, Wheeler CM et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347: 1645-1651.
17. Harper DM, Franco EL, Wheeler C et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial. Lancet 2004; 364: 1757-1765.
18. Villa LL, Costa RL, Petta CA et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6: 271-278.
19. Orem J, Otieno MW, Remick SC. AIDS-associated cancer in developing nations. Curr Opin Oncol 2004; 16: 468-476.
20. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 1436-1442.
21. Bosetti C, Malvezzi M, Chatenoud L et al. Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol 2005; 16: 489-511.
22. World Health Organization. The Word health report 2002: Reducing risks, promoting healthy life. Geneva, Switzerland: WHO 2002.
23. Corrao M, Guindon G, Sharma N, Shokoohi D. Tobacco control: Country profiles. Atlanta, GA: American Cancer Society 2000.
24. World Health Organization. Tobacco or health: A global status report. Geneva, Switzerland: WHO 1997.
25. Liu BQ, Peto R, Chen ZM et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ 1998; 317: 1411-1422.
26. Niu SR, Yang GH, Chen ZM et al. Emerging tobacco hazards in China: 2. Eady mortality results from a prospective study. BMJ 1998; 317: 1423-1424.
27. Dikshit RP, Kanhere S. Tobacco habits and risk of lung, oropharyngeal and oral cavity cancer: A population-based case-control study in Bhopal, India. Int J Epidemiol 2000; 29: 609-614.
28. Gupta PC, Mehta HC. Cohort study of all-cause mortality among tobacco users in Mumbai, India. Bull Word Health Organ 2000; 78: 877-883.
29. Peto R, Lopez AD, Boreham J et al. Mortality from tobacco in developed countries: Indirect estimation from national vital statistics. Lancet 1992; 339: 1268-1278.
30. Reibel J. Tobacco and oral diseases. Update on the evidence, with recommendations. Med Princ Pract 2003; 12 Suppl 1: 22-32.
31. Lumukana R, King T. Smoking and chewing habits of oral cancer patients in the Solomon Islands. Pac Health Dialog 2003; 10: 41-44.
32. Trivedy CR, Craig G, Warnakulasuriya S. The oral health consequences of chewing areca nut. Addict Biol 2002; 7: 115-125.
33. Gupta PC, Warnakulasuriya S. Global epidemiology of areca nut usage. Addict Biol 2002; 7: 77-83.
34. Talonu NT. Observations on betel-nut use, habituation, addiction and carcinogenesis in Papua New Guineans. PNG Med J 1989; 32: 195-197.
35. Ko YC, Chiang TA, Chang SJ, Hsieh SF. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med 1992; 21: 261-264.
36. Lu CT, Lan SJ, Hsieh CC et al. Prevalence and characteristics of areca nut chewers among junior high school students in Changhua county, Taiwan. Community Dent Oral Epidemiol 1993; 21: 370-373.
37. Yang MS, Su IH, Wen JK, Ko YC. Prevalence and related risk factors of betel quid chewing by adolescent students in southern Taiwan. J Oral Pathol Med 1996; 25: 69-71.
38. Oakley E, Demaine L, Warnakulasuriya S. Areca (betel) nut chewing habit among high-school children in the Commonwealth of the Northern Mariana Islands (Micronesia). Bull World Health Organ 2005; 83: 656-660.
39. World Health Organization. The World health report 2003 : Shaping the future. Geneva, Switzerland: WHO 2003.
40. World Health Organization. Preventing Chronic Disease: A Vital Investment. Geneva, Switzerland: WHO 2005.
41. Shimkhada R, Peabody JW. Tobacco control in India. Bull World Health Organ 2003; 81: 48-52.
42. Watkins K. Human Development Report 2005. International cooperation at a crossroads. New York, NY 10016: United Nations Development Program; 2005.
43. Liu Y, Rao K. Providing health insurance in rural china: From research to policy. J Health Polit Policy Law 2006; 31: 71-92.
44. Wu M, Xin Y, Wang H, W. Y. Private and public cross-subsidizabon: financing Beijing's health-insurance reform. Health Policy 2005; 72: 41-52.
45. Kanavos P, Ustel I, Costa-Font J. Financing and reimbursement of pharmaceuticals in Turkey. Ankara, Turkey: SUVAK 2005.
46. Twigg JL. Obligatory' medical insurance in Russia: The participants' perspective. Social Science and Medicine 1999; 49: 371-382.
47. Ministry of Health of the Russian Federation and Russian Duma. Pers comm. January 2006.
48. Arredondo A, Orozco E, De Icaza E. Evidences on weaknesses and strengths from health financing after decentralization: Lessons from Latin American countries. Int J Health Plann Manage 2005; 20: 181-204.
49. Huynen MM, Martens P, Hilderink HB. The health impacts of globalization: a conceptual framework. Global Health 2005; 1: 14.
50. Frenk J, Gomez-Dantes O. Globalization and the challenges to health systems. Health Aff (Millwood) 2002; 21: 160-165.
51. Zwi AB, Yach D. International health in the 21st century: Trends and challenges, Soc Sci Med 2002; 54: 1615-1620.
52. Sharma DC. WHO emphasis on cost-effective cancer-control strategies. Lancet Oncol 2003; 4: 7.
53. World Health Organization. Cancer Prevention and Control. Report to the Secretariat by the 58th World Health Assembly. (2005). [On-line]. http://www.who.int/mediacentre/news/releases/2003/pr27/en/ (January 10, 2006, date last accessed).
54. Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health 2005; 4: 2.
55. Alwan A. Non-communicable diseases: A major challenge to public health in the region. East Mediterr Health J 1997; 3: 6-16.
56. Chen MS Jr. Cancer health disparities among Asian Americans: What we do and what we need to do. Cancer 2005; 104: 2895-2902.